# Cabaletta Bio reports phase 1/2 data for autoimmune therapy

- Source: All News
- Published: 2026-11-08T15:04:37+00:00
- Category: Business
- Original: https://www.investing.com/news/company-news/cabaletta-bio-reports-phase-12-data-for-autoimmune-therapy-93CH-5010250
- Canonical: https://groundlevelnews.com/story/cabaletta-bio-reports-phase-1-2-data-for-autoimmune-therapy-bef30c/

Read the full report from the original publisher.

_Ground Level News shows a short summary only; the full article and all rights belong to All News._